Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia

• Tamara Bittolo,
• Federico Pozzo,
• Riccardo Bomben,
• Tiziana D’Agaro,
• Vanessa Bravin,
• Pietro Bulian,
• Francesca Maria Rossi,
• Antonella Zucchetto,
• Massimo Degan,
• Paolo Macor,
• Giovanni D’Arena,
• Annalisa Chiarenza,
• Francesco Zaja,
• Gabriele Pozzato,
• Francesco Di Raimondo,
• Davide Rossi,
• Gianluca Gaidano,
• Giovanni Del Poeta,
• Valter Gattei,
• Michele Dal Bo

Affiliations

Tamara Bittolo

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Federico Pozzo

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Riccardo Bomben

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Tiziana D’Agaro

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Vanessa Bravin

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Pietro Bulian

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Francesca Maria Rossi

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Antonella Zucchetto

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Massimo Degan

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Paolo Macor

Department of Life Sciences, University of Trieste, Italy

Giovanni D’Arena

Onco-Hematology Department, Centro di Riferimento Oncologico della Basilicata, I.R.C.C.S., Rionero in Vulture, Italy

Annalisa Chiarenza

Division of Hematology, Ferrarotto Hospital, Catania, Italy

Francesco Zaja

Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy

Gabriele Pozzato

Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy

Francesco Di Raimondo

Division of Hematology, Ferrarotto Hospital, Catania, Italy

Davide Rossi

Hematology, Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Gianluca Gaidano

Division of Hematology–Department of Translational Medicine –University of Eastern Piedmont, Novara, Italy

Giovanni Del Poeta

Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy

Valter Gattei

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy

Michele Dal Bo

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy